<DOC>
	<DOCNO>NCT00958035</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost solution 0.03 % daily upper eyelid margin ( eyelash meet skin ) compare vehicle increase overall eyelash prominence self-identified African American/ethnic black subject exhibit hypotrichosis eyelash ( inadequate enough eyelash ) .</brief_summary>
	<brief_title>Study Bimatoprost Solution Increasing Eyelash Prominence African Americans With Eyelash Hypotrichosis</brief_title>
	<detailed_description />
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>African American/ethnic black Adults least 18 year age Eyelash prominence assessment minimal moderate Subjects uneven lash longer one side Any eye disease abnormality Eye surgery Severe hyperpigmentation around eye Eyelash implant Eyelash extension application Any use eyelash growth product within 6 month Any use prescription eyelash growth product Treatments may affect hair growth Requiring eye drop medication glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>